Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [11C] methionine PET and T1c-w MRI

Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [11C] methionine PET and T1c-w MRI

Abstract Personalized treatment strategies based on non-invasive biomarkers have potential to improve patient management in patients with newly diagnosed glioblastoma (GBM). The residual tumour burden after surgery in GBM patients is a prognostic imaging biomarker. However, in clinical patient manag...

Full description

Bibliographic Details
Main Authors: Iram Shahzadi, Annekatrin Seidlitz, Bettina Beuthien-Baumann, Alex Zwanenburg, Ivan Platzek, Jörg Kotzerke, Michael Baumann, Mechthild Krause, Esther G. C. Troost, Steffen Löck
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-55092-8

Internet

https://doi.org/10.1038/s41598-024-55092-8

Similar Items